The promise of AI and CRISPR-Cas13a in cancer gene therapy is a harmony of development and hope. With the use of AI and CRISPR-Cas13a's molecular precision, as well as AI's computational power, cancer treatments may be administered with unprecedented precision and adaptability in the future.
Primary Language | English |
---|---|
Subjects | Clinical Sciences (Other) |
Journal Section | Letter to the Editor |
Authors | |
Publication Date | April 24, 2024 |
Submission Date | December 12, 2023 |
Acceptance Date | February 5, 2024 |
Published in Issue | Year 2024 Volume: 14 Issue: 1 |